How a Promising Silver-Based Complex Targets Human Cancer Cells (IMAGE)
Caption
A family of economical silver-based complexes show very promising results against a number of human cancers in laboratory tests, with very low toxicity in rat studies and minimal effects on healthy cells. One of these, UJ3, is as effective as the industry-standard drug Cisplatin in killing cancer cells in laboratory tests done on human esophageal cancer, breast cancer and melanoma. This matrix of light microscope images show a comparison of human esophageal cancer cells treated with UJ3 and Cisplatin.
Credit
Dr Zelinda Engelbrecht, University of Johannesburg
Usage Restrictions
None
License
Licensed content